821
Views
5
CrossRef citations to date
0
Altmetric
Commentary

The impact of patent eligibility on biotech patents: A flow chart for determining patent eligibility and an immune therapy case study

&
Pages 789-794 | Received 02 Dec 2014, Accepted 18 Dec 2014, Published online: 03 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shyh-Jen Wang. (2019) Drafting eligible biotech and immunotherapy claims. Human Vaccines & Immunotherapeutics 15:11, pages 2706-2712.
Read now
Bao-Chi Chang & Shyh-Jen Wang. (2016) The limited benefit of “product-by-process” claim. Human Vaccines & Immunotherapeutics 12:10, pages 2685-2687.
Read now

Articles from other publishers (3)

Soloman Saleh, Jacob George, Katharine A. Kott, Peter J. Meikle & Gemma A. Figtree. (2022) The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review. Frontiers in Cardiovascular Medicine 9.
Crossref
Jir-You Wang, Yi-Fang Tsai, Tien-Hsiang Wang & Shyh-Jen Wang. (2022) Relieving patent-eligibility barriers in biotech with a preparation or treatment method. Nature Biotechnology 40:5, pages 651-653.
Crossref
Fern R. McSorley, Jarrod W. Johnson & Gerard D. Wright. 2018. Antimicrobial Resistance in the 21st Century. Antimicrobial Resistance in the 21st Century 533 562 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.